These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 27485852)

  • 21. Fasting plasma glucose is not sufficient to detect ongoing glucose intolerance after pregnancy complicated by gestational diabetes.
    Kakad R; Anwar A; Dyer P; Webber J; Dale J
    Exp Clin Endocrinol Diabetes; 2010 Apr; 118(4):234-6. PubMed ID: 20162508
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Metabolic syndrome in subjects at high risk for type 2 diabetes: the genetic, physiopathology and evolution of type 2 diabetes (GENFIEV) study.
    Bianchi C; Miccoli R; Bonadonna RC; Giorgino F; Frontoni S; Faloia E; Marchesini G; Dolci MA; Alviggi L; Gnasso A; Consoli A; Cavalot F; Cavallo MG; Leonetti F; Giaccari A; Del Prato S;
    Nutr Metab Cardiovasc Dis; 2011 Sep; 21(9):699-705. PubMed ID: 21291660
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The cost of diagnosing Type 2 diabetes mellitus by clinical opportunistic screening in general practice.
    Pereira Gray DJ; Evans PH; Wright C; Langley P
    Diabet Med; 2012 Jul; 29(7):863-8. PubMed ID: 22313143
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Exenatide versus insulin glargine in patients with type 2 diabetes in the UK: a model of long-term clinical and cost outcomes.
    Ray JA; Boye KS; Yurgin N; Valentine WJ; Roze S; McKendrick J; Tucker DM; Foos V; Palmer AJ
    Curr Med Res Opin; 2007 Mar; 23(3):609-22. PubMed ID: 17355742
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Incidence and predictors of type 2 diabetes among Koreans: A 12-year follow up of the Korean Genome and Epidemiology Study.
    Han SJ; Kim HJ; Kim DJ; Lee KW; Cho NH
    Diabetes Res Clin Pract; 2017 Jan; 123():173-180. PubMed ID: 28043048
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Risk-stratified screening for diabetes in adults: results of the first investigation in Hungary].
    Winkler G; Hidvégi T; Vándorfi G; Jermendy G
    Orv Hetil; 2010 Apr; 151(17):691-6. PubMed ID: 20388612
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Management of raised glucose, a clinical decision tool to reduce length of stay of patients with hyperglycaemia.
    Herring R; Russell-Jones DL; Pengilley C; Hopkins H; Tuthill B; Wright J; Hordern SV; Davidson S
    Diabet Med; 2013 Jan; 30(1):81-7. PubMed ID: 22950637
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cost-effectiveness analysis of intensive blood-glucose control with metformin in overweight patients with type II diabetes (UKPDS No. 51).
    Clarke P; Gray A; Adler A; Stevens R; Raikou M; Cull C; Stratton I; Holman R;
    Diabetologia; 2001 Mar; 44(3):298-304. PubMed ID: 11317659
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Regional differences of undiagnosed type 2 diabetes and prediabetes prevalence are not explained by known risk factors.
    Tamayo T; Schipf S; Meisinger C; Schunk M; Maier W; Herder C; Roden M; Nauck M; Peters A; Völzke H; Rathmann W
    PLoS One; 2014; 9(11):e113154. PubMed ID: 25402347
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cost effectiveness of self-monitoring of blood glucose (SMBG) for patients with type 2 diabetes and not on insulin: impact of modelling assumptions on recent Canadian findings.
    Tunis SL
    Appl Health Econ Health Policy; 2011 Nov; 9(6):351-65. PubMed ID: 21892840
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Polish Multicenter Study on Diabetes Epidemiology (PMSDE)--1998-2000].
    Szybiński Z
    Pol Arch Med Wewn; 2001 Sep; 106(3):751-8. PubMed ID: 11928582
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Development and validation of a risk-score model for subjects with impaired glucose tolerance for the assessment of the risk of type 2 diabetes mellitus-The STOP-NIDDM risk-score.
    Tuomilehto J; Lindström J; Hellmich M; Lehmacher W; Westermeier T; Evers T; Brückner A; Peltonen M; Qiao Q; Chiasson JL
    Diabetes Res Clin Pract; 2010 Feb; 87(2):267-74. PubMed ID: 20022651
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Glycaemic control is essential for effective cardiovascular risk reduction across the type 2 diabetes continuum.
    Karasik A
    Ann Med; 2005; 37(4):250-8. PubMed ID: 16019723
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Routinely collected general practice data aids identification of people with hyperglycaemia and metabolic syndrome.
    Heldgaard PE; Griffin SJ
    Diabet Med; 2006 Sep; 23(9):996-1002. PubMed ID: 16922706
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Who attends a UK diabetes screening programme? Findings from the ADDITION-Cambridge study.
    Sargeant LA; Simmons RK; Barling RS; Butler R; Williams KM; Prevost AT; Kinmonth AL; Wareham NJ; Griffin SJ
    Diabet Med; 2010 Sep; 27(9):995-1003. PubMed ID: 20722672
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of the Diabetes Screening Component of a National Cardiovascular Risk Assessment Programme in England: a Retrospective Cohort Study.
    Palladino R; Vamos EP; Chang KC; Khunti K; Majeed A; Millett C
    Sci Rep; 2020 Jan; 10(1):1231. PubMed ID: 31988330
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A cost comparison of an enhanced primary care diabetes service and standard care.
    Seidu S; Gillies C; Farooqi A; Trivedi H; Than T; Brady E; Davies MJ; Khunti K
    Prim Care Diabetes; 2021 Jun; 15(3):601-606. PubMed ID: 33279438
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Incorporating polygenic risk into the Leicester Risk Assessment score for 10-year risk prediction of type 2 diabetes.
    Liu X; Littlejohns TJ; Bešević J; Bragg F; Clifton L; Collister JA; Trichia E; Gray LJ; Khunti K; Hunter DJ
    Diabetes Metab Syndr; 2024 Apr; 18(4):102996. PubMed ID: 38608567
    [TBL] [Abstract][Full Text] [Related]  

  • 39. How diabetes risk assessment tools are implemented in practice: a systematic review.
    Dhippayom T; Chaiyakunapruk N; Krass I
    Diabetes Res Clin Pract; 2014 Jun; 104(3):329-42. PubMed ID: 24485859
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Screening.
    J Health Serv Res Policy; 2017 Jan; 22(1):45-52. PubMed ID: 28430003
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.